Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components

Chinese Medicine

Volumn 6, Issue , 2011, Pages

  Liao, Jyh Fei ^a   Chiou, Wen Fei ^b   Shen, Yuh Chiang ^b   Wang, Guei Jane ^b   Chen, Chieh Fu ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; ARACHIDONATE 5 LIPOXYGENASE; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CARDIOVASCULAR AGENT; CYTOKINE; DEHYDROEVODIAMINE; DERMATOLOGICAL AGENT; EVOCARPINE; EVODIA FRUIT EXTRACT; EVODIA RUTAECARPA EXTRACT; EVODIAMINE; GASTROINTESTINAL AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; LYMPHOTOXIN; NEUROPEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSIGLITAZONE; RUTAECARPINE; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ALZHEIMER DISEASE; ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CHILL; DIABETES MELLITUS; ENDOTOXEMIA; EVODIA; EVODIA RUTAECARPA; FOOD INTAKE; HELICOBACTER INFECTION; HUMAN; MEDICINAL PLANT; MONONUCLEAR CELL; OBESITY; PLASMODIUM BERGHEI INFECTION; REVIEW; STOMACH DISCOMFORT;

EID: 79851514952     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-6-6     Document Type: Review

References (107)

1. Angus DC. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
2. Smyth EM, Burke A, Fitzgerald GA. Lipid-derived autacoids: Eicosanoids and platelet-activating factor. Goodman and Gilman's the Pharmacological Basis of Therapeutics 2006, 653-670. New York: McGraw-Hill Med Pub Div, Brunton LL, Lazo JS, Parker KL, 11.
3. Elliott MJ, Chitham K, Theoharis LT. The effects of plant flavonoids on mammalian cells. Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000, 52:673-751.
4. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
5. Stefanovic Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arthritis Rheum 1993, 36(8):1036-1044. 10.1002/art.1780360803, 8343180.
6. Chiou WF, Liao JF, Chen CF. Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J Nat Prod 1996, 59(4):374-378. 10.1021/np960161+, 8699182.
7. Chiou WF, Liao JF, Shum AY, Chen CF. Mechanisms of vasorelaxant effect of dehydroevodiamine: A bioactive isoquinazolinocarboline alkaloid of plant origin. J Cardiovasc Pharmacol 1996, 27(6):845-853. 10.1097/00005344-199606000-00012, 8761852.
8. Chiou WF, Shum AY, Liao JF, Chen CF. Studies of the cellular mechanisms underlying the vasorelaxant effects of rutaecarpine, a bioactive component extracted from a herbal drug. J Cardiovasc Pharmacol 1997, 29(4):490-498. 10.1097/00005344-199704000-00010, 9156359.
9. Wang GJ, Shan J, Pang PKT, Yang MCM, Chou CJ, Chen CF. The vasorelaxing action of rutaecarpine: Direct paradoxical effects of intracellular calcium concentration of vascular smooth muscle and endothelial cells. J Pharmacol Exp Ther 1996, 276:1016-1021.
10. Wang GJ, Wu XC, Chen CF, Lin LC, Huang YT, Shan J, Pang PKT. Vasorelaxing action of rutaecarpine: Effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells. J Pharmacol Exp Ther 1999, 289:1237-1244.
11. Chiou WF, Chen CF. Pharmacological profile of evodiamine in isolated rabbit corpus cavernosum. Eur J Pharmacol 2002, 446:151-159. 10.1016/S0014-2999(02)01762-4, 12098597.
12. Chiou WF, Sung YJ, Liao JF, Shum AY, Chen CF. Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. J Nat Prod 1997, 60(7):708-711. 10.1021/np960495z, 9249975.
13. Chiou WF, Ko HC, Chen CF, Chou CJ. Evodia rutaecarpa, protects against circulation failure and organ dysfunction in endotoxaemic rats through modulating nitric oxide release. J Pharm Pharmacol 2002, 54:1399-1405. 10.1211/002235702760345491, 12396303.
14. Ko HC, Wang YH, Liou KT, Chen CM, Chen CH, Wang WY, Chang S, Hou YC, Chen KT, Chen CF, Shen YC. Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur J Pharmacol 2007, 555(2-3):211-217. 10.1016/j.ejphar.2006.10.002, 17109845.
15. Choi YH, Shin EM, Kim YS, Cai XF, Lee JJ, Kim HP. Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms. Arch Pharm Res 2006, 29(4):293-297. 10.1007/BF02968573, 16681034.
16. Noh EJ, Ahn KS, Shin EM, Jung SH, Kim YS. Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-Kappa B activation in RAW 264.7 macrophages. Life Sci 2006, 79:695-701. 10.1016/j.lfs.2006.02.020, 16554073.
17. Liu YN, Pan SL, Liao CH, Huang DY, Guh JH, Peng CY, Chang YL, Teng CM. Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1 alpha accumulation in RAW 264.7. Shock 2009, 32(3):263-269. 10.1097/SHK.0b013e31819940cb, 19106818.
18. Moon TC, Murakami M, Kudo I, Son KH, Kim HP, Kang SS, Chang HW. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflamm Res 1999, 48(12):621-625. 10.1007/s000110050512, 10669112.
19. Wang Y, Lei F, Wang S, Hu J, Zhan H, Xing D, Du L. Regulatory effects of Wuzhuyutang (Evodia prescription) and its consisting herbs on TPH2 promoter. Zhongguo Zhong Yao Za Zhi 2009, 34(17):2261-2264.
20. Chang CP, Chang JY, Wang FY, Tseng J, Chang JG. The effect of Evodia rutaecarpa extract on cytokine secretion by human mononuclear cells in vitro. Am J Chin Med 1995, 23(2):173-180. 10.1142/S0192415X95000237, 7572779.
21. Chang JY, Yang TY, Chang CP, Chang JG. The effect of 'chi-han (hot nature)' Chinese herbs on the secretion of IL-1 beta and TNF-alpha by mononuclear cells. Kaohsiung J Med Sci 1996, 12(1):18-24.
22. Bobik A, Kalinina N. Tumor necrosis factor receptor and ligand superfamily family members TNFRSF 14 and LIGHT: New players in human atherogenesis. Arterioscler Thromb Vasc Biol 2001, 21:1873-1875.
23. Heo SK, Yun HJ, Yi HS, Noh EK, Park SD. Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation. J Cell Biochem 2009, 107(1):123-133. 10.1002/jcb.22109, 19241441.
24. Caterina M, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001, 24:487-517. 10.1146/annurev.neuro.24.1.487, 11283319.
25. Peng L, Li YJ. The vanilloid receptor TRPV-1: Role in cardiovascular and gastrointestinal protection. Eur J Pharmacol 2010, 627(1-3):1-7. 10.1016/j.ejphar.2009.10.053, 19879868.
26. Chow SY, Chen SM, Yang CM. Pharmacological studies on Chinese herbs (3): Analgesic effects of 27 Chinese drugs in mice. J Formosan Med Asso 1976, 75:349-357.
27. Matsuda H, Wu TX, Tanaka T, Linuma M, Kubo M. Antinociceptive activities of 70% methanol extract of Evodiae Fructus (fruit of Evodia rutaecarpa var. bodinieri ) and its alkaloidal components. Biol Pharm Bull 1997, 20(3):243-248.
28. Matsuda H, Yoshikawa M, Linuma M, Kobo M. Antinociceptive and anti-inflammatory activities of limonin isolated from the fruits of Evodia rutaecarpa var. bodinieri. Planta Med 1998, 64(4):339-342. 10.1055/s-2006-957447, 9619117.
29. Kobayashi Y, Nakano Y, Hoshikuma KM, Yokoo Y, Kamiya T. The bronchoconstrictive action of evodiamine, an indoloquinazoline alkaloid isolated from the fruits of Evodia rutaecarpa, on guinea-pig isolated bronchus: Possible involvement on vanilloid receptors. Planta Med 2000, 66(6):526-530. 10.1055/s-2000-8615, 10985078.
30. Kobayashi Y, Hoshikuma K, Nakano Y, Yokoo Y, Kamiya T. The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: Possible involvement of vanilloid receptors. Planta Med 2001, 67(3):244-248. 10.1055/s-2001-12008, 11345696.
31. Kobayashi Y. The nociceptive and anti-nociceptive effects of evodiamine from fruits of Evodia rutaecarpa in mice. Planta Med 2003, 69(5):425-428. 10.1055/s-2003-39701, 12802723.
32. Pearce LV, Petukhov PA, Szabo T, Kedei N, Bizik F, Kozikowski AP, Blumberg PM. Evodiamine functions as an agonist for the vanilloid receptor TRPVI. Org Biomol Chem 2004, 2(16):2281-2286. 10.1039/b404506h, 15305207.
33. Rang WQ, Du YH, Hu CP, Ye F, Tan GS, Deng HW, Li YJ. Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis. Naunyn Schmiedebergs Arch Pharmacol 2003, 367(3):306-311. 10.1007/s00210-002-0677-0, 12644904.
34. Rang WQ, Du YH, Hu CP, Ye F, Xu KP, Peng J, Deng HW, Li YJ. Protective effects of evodiamine on myocardial ischemia-reperfusion injury in rats. Planta Med 2004, 70(12):1140-1143. 10.1055/s-2004-835841, 15643547.
35. Yi HH, Rang WQ, Deng PY, Hu CP, Liu GZ, Tan GS, Xu KP, Li YJ. Protective effects of rutaecarpine in cardiac anaphylactic injury is mediated by CGRP. Plant Med 2004, 70(12):1135-1139.
36. Yu J, Tan GS, Deng PY, Xu KP, Hu CP, Li YJ. Involvement of CGRP in the inhibitory effect of rutaecarpine on vasoconstriction induced by anaphylaxis in guinea pig. Regul Pept 2005, 125(1-3):93-97. 10.1016/j.regpep.2004.08.001, 15582719.
37. Hu CP, Xiao L, Deng HW, Li YJ. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin release-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med 2002, 68(8):705-709. 10.1055/s-2002-33794, 12221592.
38. Li D, Zhang XL, Chen L, Yang Z, Deng HW, Peng L, Li YJ. Calcitonin gene-related peptide mediates the cardioprotective effects of rutaecarpine against ischaemia-perfusion injury in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2009, 36(7):662-667. 10.1111/j.1440-1681.2008.05136.x, 19076981.
39. Dai Z, Xiao J, Lin SY, Cui L, Hu GY, Jiang DJ. Rutaecarpine inhibits hypoxia/reoxygenation-induced apoptosis in rat hippocampal neurons. Neuropharmacology 2008, 55(8):1307-1312. 10.1016/j.neuropharm.2008.08.030, 18809421.
40. Wang L, Hu CP, Deng PY, Shen SS, Zhu HQ, Ding JS, Tan GS, Li YJ. The protective effects of rutaecarpine on gastric mucosa injury in rats. Planta Med 2005, 71(5):416-419. 10.1055/s-2005-864135, 15931578.
41. Liu YZ, Zhou Y, Li D, Wang L, Hu GY, Peng J, Li YJ. Reduction of asymmetric dimethylarginine in the protective effects of rutaecarpine on gastric mucosal injury. Can J Physiol Pharmacol 2008, 86(10):675-681. 10.1139/Y08-073, 18841172.
42. Deng PY, Li YJ. Calcitonin gene-related peptide and hypertension. Peptides 2005, 26(9):1675-1685.
43. Márquez-Rodas L, Longo F, Rothlin RP, Balfagón G. Phathophysiology and the therapeutic possibilities of calcitonin gene-related peptide in hypertension. J Physiol Biochem 2006, 62(1):45-46.
44. Hu CP, Xiao L, Deng HW, Li YJ. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide. Planta Med 2003, 69(2):125-129. 10.1055/s-2003-37703, 12624816.
45. Deng PY, Ye F, Cai WJ, Tan GS, Hu CP, Deng HW, Li YJ. Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine. J Hypertens 2004, 22(9):1819-1829. 10.1097/00004872-200409000-00028, 15311112.
46. Qin XP, Zeng SY, Li D, Chen QQ, Luo D, Zhang Z, Hu GY, Deng HW, Li YJ. Calcitonin gene-related peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats. J Cardiovasc Pharmacol 2007, 50(6):654-659. 10.1097/FJC.0b013e3181579e7e, 18091582.
47. Li D, Peng J, Xin HY, Luo D, Zhang YS, Zhou Z, Jiang DJ, Deng HW, Li YJ. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats. Peptides 2008, 29(10):1781-1788. 10.1016/j.peptides.2008.06.010, 18625276.
48. Qin XP, Zeng SY, Tian HH, Deng SX, Ren JF, Zheng YB, Li D, Li YJ, Liao DF, Chen SY. Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats. Clin Exp Pharmacol Physiol 2009, 36(3):319-324. 10.1111/j.1440-1681.2008.05079.x, 2698710, 19018804.
49. Sheu JR, Hung WC, Lee YM, Yen MH. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Eur J Pharmacol 1996, 318(2-3):469-475. 10.1016/S0014-2999(96)00789-3, 9016940.
50. Sheu JR, Kan TC, Hung WC, Su CH, Lin CH, Lee YM, Yen MH. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C. Thromb Res 1998, 92(2):53-64. 10.1016/S0049-3848(98)00112-1, 9792112.
51. Sheu JR, Hung WC, Wu CH, Lee YM, Yen MH. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in vivo experiments. Br J Pharmacol 2000, 110(1):110-115.
52. Zhou Z, Peng J, Wang CJ, Li D, Li TT, Hu CP, Chen XP, Li YL. Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertens 2010, 28(5):931-939. 10.1097/HJH.0b013e3283399326, 20375903.
53. Ding JS, Gao R, Li D, Peng J, Ran LL, Li YL. Solid dispersion of rutaecarpine improved its antihypertensive effect in spontaneously hypertensive rats. Biopharm Drug Dispos 2008, 29(9):495-500. 10.1002/bdd.634, 19016276.
54. Chen Z, Hu G, Li D, Chen J, Li Y, Zhou H, Xie Y. Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member I (TRPVI). Bioorg Med Chem 2009, 17(6):2351-2359. 10.1016/j.bmc.2009.02.015, 19254847.
55. Selkoe DJ, Podlisny MB. Deciphering the genetic basis of Alzheimer's disease. Ann Rev Genomics Hum Genet 2002, 3:67-99.
56. Perry EK. The cholinergic hypothesis-ten years on. Br Med Bull 1986, 42:63-69.
57. Cumming JL, Vinters HV, Cole GM, Khachaturian ZS. Alzeheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998, 51(Suppl 1):S2-S17.
58. Parihar MS, Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 2004, 11(5):456-467. 10.1016/j.jocn.2003.12.007, 15177383.
59. Haji A, Momose Y, Takeda R, Nakanishi S, Hiriachi T, Arisawa M. Increased feline cerebral blood flow induced by dehydroevodiamine hydrochloride from Evodia rutaecarpa. J Nat Prod 1994, 57(3):387-389. 10.1021/np50105a009, 8201313.
60. Park CH, Kim SH, Choi W, Lee YJ, Kim JS, Kang SS, Suh YH. Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa. Planta Med 1996, 62(5):405-409. 10.1055/s-2006-957926, 8923803.
61. Park CH, Lee YJ, Lee SH, Choi SH, Kim HS, Jeong SJ, Kim SS, Suh YH. Dehydroevodiamine.HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance. J Neurochem 2000, 74(1):244-253. 10.1046/j.1471-4159.2000.0740244.x, 10617126.
62. Wang HH, Chou CJ, Liao JF, Chen CF. Dehydroevodiamine attenuates beta-amyloid peptide-induced amnesia in mice. Eur J Pharmacol 2001, 413(2-3):221-225. 10.1016/S0014-2999(00)00913-4, 11226396.
63. Peng JH, Zhang CE, Wei W, Hong XP, Pang XP, Wang JZ. Dehydroevodiamine attenuates tau hyerphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats. Neuropharmacology 2007, 52(7):1521-1527. 10.1016/j.neuropharm.2007.02.008, 17434540.
64. Park CH, Choi SH, Kim CH, Seo JH, Koo JW, Rah JC, Kim HS, Jeong SJ, Joo WS, Lee YL, Kim YS, Kim MS, Suh YH. General pharmacology of indole [2', 3':3,4]pyridol[2,1-b]quinazolinium-5,7,8,13-tetrahydro-14-methyl-5-oxo-chloride, a new anti-dementia agent. Arzneimittelforschung 2003, 53(6):393-401.
65. Decker M. Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine. Eur J Med Chem 2005, 40(3):305-313. 10.1016/j.ejmech.2004.12.003, 15725500.
66. Park EJ, Suh YH, Kim JY, Choi S, Lee CJ. Long-lasting facilitation by dehydroevodiamine HCI of synaptic responses evoked in the CA1 region of rat hippocampal slices. Neuroreport 2003, 14(3):399-403. 10.1097/00001756-200303030-00020, 12634491.
67. Lim DK, Lee YB, Kim HS. Effects of dehydroevodiamine exposure on glutamate release and uptake in the cultured cerebellar cells. Neurochem Res 2004, 29(2):407-411. 10.1023/B:NERE.0000013745.17014.a3, 15002738.
68. Fang J, Liu R, Tian Q, Hong XP, Wang SH, Cao FY, Pan XP, Wang JZ. Dehydroevodiamine attenuates calyculin A-induced tau hyperphosphorylation in rat brain slices. Acta Pharmacol Sin 2007, 28(11):1717-1723. 10.1111/j.1745-7254.2007.00655.x, 17959021.
69. Kim ST, Kim JD, Lyu YS, Lee MY, Kang HW. Neuroprotective effect of some plant extracts in cultured CT105-induced PC12 cells. Biol Pharm Bull 2006, 29(10):2021-2024. 10.1248/bpb.29.2021, 17015944.
70. Kano Y, Zong QN, Komatsu K. Pharmacological properties of galenical preparation, XIV. Body temperature retaining effect of the Chinese traditional medicine, 'goshuyu-to' and component crude drugs. Chem Pharm Bull (Tokyo) 1991, 39(3):690-692.
71. Tsai TH, Lee TF, Chen CF, Wang LC. Thermoregulatory effects of alkaloids isolated from Wu-Chu-Yu in afebrile and febrile rats. Pharmacol Biochem Behav 1995, 50(2):293-298. 10.1016/0091-3057(94)00317-C, 7740070.
72. Kobayashi Y, Nakano Y, Kizaki M, Hoshikuma K, Yokoo Y, Kamiya T. Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Med 2001, 67(7):628-633. 10.1055/s-2001-17353, 11582540.
73. Wang T, Wang Y, Kontani Y, Kobayashi Y, Sato Y, Mori N, Yamashita H. Evodiamine improves diet-induced obesity in a uncoupling proteun-1-independent manner: Involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling. Endocrinology 2008, 149(1):358-366. 10.1210/en.2007-0467, 17884939.
74. Wang T, Wang Y, Yamashita H. Evodiamine inhibits adipogenesis via the EGFR-PKC alpha-ERK signaling pathway. FEBS 2009, 583(22):3655-3659.
75. Hu Y, Fahmy H, Zjawiony JK, Davies GE. Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation. Fitoterapia 2010, 81(4):259-268. 10.1016/j.fitote.2009.09.012, 19799972.
76. Bak EJ, Park HG, Kim JM, Kin JM, Yoo YJ, Cha JH. Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. Int J Obes (Lond) 2010, 34(2):250-260. 10.1038/ijo.2009.223, 19859078.
77. Willie JT, Chemelli RM, Sinton CM, Yanagisawa W. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Neuroscience 2001, 24:429-458.
78. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flie E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998, 396:670-674. 10.1038/25341, 9872314.
79. Wolfrum C, Besser D, Luca E, Stoffel M. Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc Natl Acad Sci USA 2003, 100:11624-11629. 10.1073/pnas.1931483100, 208808, 14500912.
80. Silva JP, Von Meyenn F, Howell J, Thorens B, Wolfrum C. Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 2009, 462:646-651. 10.1038/nature08589, 19956259.
81. Shi J, Yan J, Lei Q, Zhao J, Chen K, Yang D, Zhaox X, Zhang Y. Intragastric administration of evodiamine suppresses NPY and AgRP gene expression in the hypothalamus and decreases food intake in rats. Brain Res 2009, 1247:71-78. 10.1016/j.brainres.2008.09.091, 18955035.
82. Kim SJ, Lee SJ, Lee S, Chae S, Han MD, Mar W, Nam KW. Rutaecarpine ameliorates body weight gain through the inhibition of orexigenic neuropeptides NPY and AgRP in mice. Biochem Biophys Res Commun 2009, 389(3):437-442. 10.1016/j.bbrc.2009.08.161, 19732749.
83. Suzen S, Buyukbingol E. Recent studies of aldose reductase enzyme inhibition for diabetic complications. Curr Med Chem 2003, 10(15):1329-1352. 10.2174/0929867033457377, 12871133.
84. Kato A, Yasuko H, Goto H, Hollinshead J, Nash RJ, Adachi I. Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity. Phytomedicine 2009, 16(2-3):258-261. 10.1016/j.phymed.2007.04.008, 17498942.
85. Yu LL, Liao JF, Chen CF. Anti-diarrheal effect of water extract of Evodia Fructus in mice. J Ethnopharmacol 2000, 73(1-2):39-45. 10.1016/S0378-8741(00)00267-1, 11025137.
86. Yu X, Wu DZ. Protective effects of Evodia rutaecarpa, water extract on ethanol-induced rat gastric lesions. Zhongguo Zhong Yao Za Zhi 2006, 31(21):1801-1803.
87. Yu X, Wu DZ, Yuam JY, Zhang RR, Hu ZB. Gastroprotective effect of fructus evodiae water extract on ethanol-induced gastric lesions in rats. Am J Chin Med 2006, 34(6):1027-1035. 10.1142/S0192415X06004491, 17163591.
88. Wu CL, Hung CR, Chang FY, Lin LC, Pau KY, Wang PS. Effects of evodiamine on gastrointestinal motility in male rats. Eur J Pharmacol 2002, 457(2-3):169-176. 10.1016/S0014-2999(02)02687-0, 12464363.
89. Zhang T, Wang MW, Chen SW. Anti-emetic effect of ethanol extract from 'Wuzhuyu broth'. Zhougguo Zhong Yao Za Zhi 2002, 27(11):862-866.
90. Kim BJ, Kim JH, Kim HP, Heo MY. Biological screening of 100 plant extracts for cosmetic use (II): Anti-oxidative activity and free radical scavenging activity. Int J Cosmet Sci 1997, 19(6):299-307. 10.1111/j.1467-2494.1997.tb00194.x, 18505484.
91. Shin YW, Bae EA, Cai XF, Lee JJ, Kim DH. In vitro and in vivo antiallergic effects on the fruits of Evodia rutaecarpa and its constituents. Biol Pharm Bull 2007, 30(1):197-199. 10.1248/bpb.30.197, 17202687.
92. Ho JN, Lee YH, Lee YD, Jun WJ, Kim HK, Hong BS, Shin DH, Cho HY. Inhibitory effect of aucubin isolated from Eucommia ulmoides against UVB-induced matrix metalloproteinase-1 production in human skin fibroblasts. Biosci Biotechnol Biochem 2005, 69(11):2227-2231. 10.1271/bbb.69.2227, 16306708.
93. Yarosh DB, Galvin JW, Nay SL, Pena AV, Canning MT, Broen DA. Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine. J Dermatol Sci 2006, 42(1):13-21. 10.1016/j.jdermsci.2005.12.009, 16423507.
94. Beak SM, Paek SH, Jahng Y, Lee YS, Kim JA. Inhibition of UVA irradiation-modulated signaling pathways by rutaecarpine, a quinazolinocarboline alkaloid, in human keratinocytes. Eur J Pharmacol 2004, 49(1-3):19-25.
95. Yamahara J, Yamada T, Kitani T, Naitoh Y, Fujmura H. Antianoxic action and active constituents of Evodia Fructus. Chem Pharm Bull (Tokyo) 1989, 37(7):1820-1822.
96. Yamahara J, Yamada T, Kitani T, Naitoh Y, Fujimura H. Antianoxic action of evodiamine, an alkaloid in Evodia rutaecarpa fruit. J Ethnopharmacol 1989, 27(1-2):185-192. 10.1016/0378-8741(89)90090-1, 2615419.
97. Zheng MS, Zhang YZ. Anti-HBsAg herbs employing ELISA technique. Zhongguo Zhong Xi Yi Jie He Za Zhi 1990, 10(9):560-562.
98. Perrett S, Whitfield PJ. Atanine (3-dimethylallyl-4-methoxy-2-quinolone), an alkaloid with anthelmintic activity from the Chinese medicinal plant, Evodia rutaecarpa. Planta Med 1995, 61(3):276-278. 10.1055/s-2006-958073, 7617774.
99. Rho TC, Bae EA, Kim DH, Oh WK, Kim BY, Ahn JS, Lee HS. Anti-Helicobacter pylori activity of quinolone alkaloids from Evodiae Fructus. Biol Pharm Bull 1999, 22(10):1141-1143.
100. Hamasaki N, Ishii E, Tominaga K, Tezuka Y, Nagaoka T, Kadota S, Kuroki T, Yano I. Highly selective antibacterial activity of novel alkyl quinolone alkaloids from a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori in vitro. Microbiol Immunol 2000, 44(1):9-15.
101. Tominaga K, Higuchi K, Hamasaki N, Hamaguchi M, Takashima T, Tanigawa T, Watanabe T, Fujiwara Y, Tezuke Y, Nagaoka T, Kadota S, Ishii E, Kobayashi K, Arakawa T. In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori. J Antimicrob Chemother 2002, 50(4):547-552. 10.1093/jac/dkf159, 12356800.
102. Tominaga K, Higuchi K, Hamasaki N, Tanigawa T, Sasaki E, Watanabe T, Fujiwara Y, Oshitani N, Arakawa T, Ishii E, Tezuka Y, Nagaoka T, Kadota S. Antibacterial activity of a Chinese herb medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori. Nippon Rinsho 2005, 63(Suppl 11):592-599.
103. Tang Y, Wu F, Feng X, Huang L. Studies on synthesis and bioactivity of 2-alkenyl-4(1H)-quinolone. Yaoxue Xuebao 1998, 33(4):269-274.
104. Thuille N, Fille M, Nagl M. Bactericidal activity of herbal extracts. Int J Hyg Environ Health 2003, 206(3):217-221. 10.1078/1438-4639-00217, 12872531.
105. Khan MR, Kihara M, Omolos AD. Antimicrobial activity of Evodia elleryana. Fitoterapia 2000, 71(1):72-74. 10.1016/S0367-326X(99)00110-0, 11449475.
106. Barrows LR, Powan E, Pond CD, Matainaho T. Anti-TB activity of Evodia elleryana bark extract. Fitoterapia 2007, 78(3):250-252. 10.1016/j.fitote.2006.12.001, 2754760, 17350179.
107. Ratsimamanga-Urverg S, Rasoanivo P, Rakoto-Ratsimamanga A, Le Bras J, Ramiliarisoa O, Savel J, Coulaud JP. Antimalarial activity and cytotoxicity of Evodia fatraina stem bark extracts. J Ethnopharmacol 1991, 33(3):231-236. 10.1016/0378-8741(91)90082-O, 1921419.